Cart
sales@molnova.com
PiB
CAS No. 566169-93-5
PiB( Pittsburgh Compound-B | 6-OH-BTA-1 )
Catalog No. M27357 CAS No. 566169-93-5
PiB is a standard for analysis of 11C-PiB. 11C-PiB is a β-amyloid PET imaging tracer for Alzheimer's disease diagnosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 165 | In Stock |
|
| 50MG | 248 | In Stock |
|
| 100MG | 372 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePiB
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiB is a standard for analysis of 11C-PiB. 11C-PiB is a β-amyloid PET imaging tracer for Alzheimer's disease diagnosis.
-
DescriptionPiB is a standard for analysis of 11C-PiB. 11C-PiB is a β-amyloid PET imaging tracer for Alzheimer's disease diagnosis.
-
In Vitro——
-
In Vivo——
-
SynonymsPittsburgh Compound-B | 6-OH-BTA-1
-
PathwayOthers
-
TargetOther Targets
-
RecptorHCMV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number566169-93-5
-
Formula Weight256.32
-
Molecular FormulaC14H12N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCNc1ccc(cc1)-c1nc2ccc(O)cc2s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khan AS, et al. High-throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post-translational modification. J Gen Virol. 2017 Apr;98(4):754-768.
molnova catalog
related products
-
Isostearic acid
Isostearic acid (Isooctadecanoic acid) is an active ingredient in imiquimod formulations that promotes the entry of imiquimod or peripherally secreted cytokines into the brain, and can be used to induce psoriasis-like disease models.
-
Opnurasib
Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.
-
(Rac)-BRD0705
(Rac)-BRD0705 is a less active racemate of BRD0705. BRD0705 is an effective and selective inhibitor of GSK3α.
